glp-1 gip Mechanisms underlying GLP-1, GIP, and DPP-4 glucose regulation Targeting GLP-1, GIP & GCG

Akt-dependent regulation of NF-B is controlled by mTOR and Raptor in association with IKK

maximum use concentration of 0.10.6% in topical products Recommended Dosage Oral supplement : 250500 mg daily (some protocols use up to 1,0002,000 mg initially) Topical formulations : 0.10.6% of total formula, added during cool-down phase Classic liposomal or higher-dose forms may be used under medical/generic supervision for accelerated results

Testers considered improvements in shade, stain removal, speed of results, ease of application, sensitivity, and overall value

Do not wax or shave the treated area Waxing or shaving the treated area can cause irritation and make the skin more sensitive